Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Martina Musella¹, Andrea Guarracino^{2

3}, Nicoletta Manduca¹, Claudia Galassi^{1

4}, Eliana Ruggiero⁵, Alessia Potenza⁵, Ester Maccafeo¹, Gwenola Manic^{6

7}, Luca Mattiello^{6

7}, Sara Soliman Abdel Rehim^{2

6}, Michele Signore⁸, Marco Pietrosanto², Manuela Helmer-Citterich², Matteo Pallocca⁹, Maurizio Fanciulli¹⁰, Tiziana Bruno¹⁰, Francesca De Nicola¹⁰, Giacomo Corleone¹⁰, Anna Di Benedetto¹¹, Cristiana Ercolani¹¹, Edoardo Pescarmona¹¹, Laura Pizzuti¹², Francesco Guidi^{1

13}, Francesca Sperati¹⁴, Sara Vitale¹, Daniele Macchia¹⁵, Massimo Spada¹⁵, Giovanna Schiavoni¹⁶, Fabrizio Mattei¹⁶, Adele De Ninno¹⁷, Luca Businaro¹⁷, Valeria Lucarini¹⁸, Laura Bracci¹⁶, Eleonora Aricò¹⁹, Giovanna Ziccheddu²⁰, Francesco Facchiano¹⁶, Stefania Rossi¹⁶, Massimo Sanchez²¹, Alessandra Boe²¹, Mauro Biffoni¹⁶, Ruggero De Maria^{22

23}, Ilio Vitale^{24

25}, Antonella Sistigu^{26

27

28}

Affiliations

¹ Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
² Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
³ Genomics Research Centre, Human Technopole, Milan, Italy.
⁴ Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
⁵ Experimental Hematology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁶ Italian Institute for Genomic Medicine (IIGM), Candiolo, Italy.
⁷ Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
⁸ RPPA Unit, Proteomics Area, Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
⁹ UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
¹⁰ SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
¹¹ Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
¹² Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
¹³ Fondazione Policlinico Universitario 'A. Gemelli' - IRCCS, Rome, Italy.
¹⁴ UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS San Gallicano Dermatological Institute, Rome, Italy.
¹⁵ Center of Animal Research and Welfare, Istituto Superiore di Sanità, Rome, Italy.
¹⁶ Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
¹⁷ Institute for Photonics and Nanotechnologies, Italian National Research Council, Rome, Italy.
¹⁸ Department of Paediatric Haematology/Oncology and of Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
¹⁹ FaBioCell, Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
²⁰ Oncogenomics and Epigenetics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
²¹ Cytometry Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
²² Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy. ruggero.demaria@unicatt.it.
²³ Fondazione Policlinico Universitario 'A. Gemelli' - IRCCS, Rome, Italy. ruggero.demaria@unicatt.it.
²⁴ Italian Institute for Genomic Medicine (IIGM), Candiolo, Italy. ilio.vitale@gmail.com.
²⁵ Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy. ilio.vitale@gmail.com.
²⁶ Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy. antonella.sistigu@unicatt.it.
²⁷ Fondazione Policlinico Universitario 'A. Gemelli' - IRCCS, Rome, Italy. antonella.sistigu@unicatt.it.
²⁸ Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. antonella.sistigu@unicatt.it.

PMID: 39289560
PMCID: PMC11518983
DOI: 10.1038/s41590-024-01984-w

Published Erratum

Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Martina Musella et al. Nat Immunol. 2024 Nov.

. 2024 Nov;25(11):2166.

doi: 10.1038/s41590-024-01984-w.

Authors

Affiliations

¹ Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
² Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
³ Genomics Research Centre, Human Technopole, Milan, Italy.
⁴ Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
⁵ Experimental Hematology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁶ Italian Institute for Genomic Medicine (IIGM), Candiolo, Italy.
⁷ Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
⁸ RPPA Unit, Proteomics Area, Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
⁹ UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
¹⁰ SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
¹¹ Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
¹² Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
¹³ Fondazione Policlinico Universitario 'A. Gemelli' - IRCCS, Rome, Italy.
¹⁴ UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS San Gallicano Dermatological Institute, Rome, Italy.
¹⁵ Center of Animal Research and Welfare, Istituto Superiore di Sanità, Rome, Italy.
¹⁶ Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
¹⁷ Institute for Photonics and Nanotechnologies, Italian National Research Council, Rome, Italy.
¹⁸ Department of Paediatric Haematology/Oncology and of Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
¹⁹ FaBioCell, Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
²⁰ Oncogenomics and Epigenetics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
²¹ Cytometry Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
²² Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy. ruggero.demaria@unicatt.it.
²³ Fondazione Policlinico Universitario 'A. Gemelli' - IRCCS, Rome, Italy. ruggero.demaria@unicatt.it.
²⁴ Italian Institute for Genomic Medicine (IIGM), Candiolo, Italy. ilio.vitale@gmail.com.
²⁵ Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy. ilio.vitale@gmail.com.
²⁶ Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy. antonella.sistigu@unicatt.it.
²⁷ Fondazione Policlinico Universitario 'A. Gemelli' - IRCCS, Rome, Italy. antonella.sistigu@unicatt.it.
²⁸ Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. antonella.sistigu@unicatt.it.

PMID: 39289560
PMCID: PMC11518983
DOI: 10.1038/s41590-024-01984-w

No abstract available

PubMed Disclaimer

Erratum for

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Musella M, Guarracino A, Manduca N, Galassi C, Ruggiero E, Potenza A, Maccafeo E, Manic G, Mattiello L, Soliman Abdel Rehim S, Signore M, Pietrosanto M, Helmer-Citterich M, Pallocca M, Fanciulli M, Bruno T, De Nicola F, Corleone G, Di Benedetto A, Ercolani C, Pescarmona E, Pizzuti L, Guidi F, Sperati F, Vitale S, Macchia D, Spada M, Schiavoni G, Mattei F, De Ninno A, Businaro L, Lucarini V, Bracci L, Aricò E, Ziccheddu G, Facchiano F, Rossi S, Sanchez M, Boe A, Biffoni M, De Maria R, Vitale I, Sistigu A. Musella M, et al. Nat Immunol. 2022 Sep;23(9):1379-1392. doi: 10.1038/s41590-022-01290-3. Epub 2022 Aug 24. Nat Immunol. 2022. PMID: 36002648 Free PMC article.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Affiliations

Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Authors

Affiliations

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources